微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
Trump strikes nine more deals with drugmakers to lower prices
RSS 官方收录 · 可信分层展示
关键摘要
WASHINGTON — President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies joining the 17 that reached agreements with the administration previously.…
- The new companies striking deals — Alcon, Astellas, BeOne, BridgeBio, …
- patients at prices comparable to the lowest prices in peer countries, …
- medical stockpiles.
摘要引擎：抽取
正文提要
WASHINGTON — President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies joining the 17 that reached agreements with the administration previously.
The new companies striking deals — Alcon, Astellas, BeOne, BridgeBio, CSL, Sun Pharma, Kyowa Kirin, Teva, and UCB — made pledges similar to those made by larger drugmakers before them: to sell new medications to U.S. patients at prices comparable to the lowest prices in peer countries, to offer their drugs to state Medicaid programs at “most-favored nation” prices, and, in some instances, to bolster domestic manufacturing and contribute to the U.S. medical stockpiles. In return, it’s believed at least some of the companies will avoid tariffs.